Diastonia is a neurological movement disorder characterized by constant muscle contraction, abnormal muscle tension, and involuntary, painful muscle contractions. Statistics show that more than 300,000 people in North America are affected by this disorder which is the third most common movement disorder after Parkinson’s disease and nerve shock. These involuntary and sometimes painful movements affect either the muscle alone or a whole group of muscles such as the arms, neck or legs or even the whole body. People with dystonia usually do not have mental disorders and have normal intelligence.
Several forensic studies and case reports examining the use of medical cannabis to control the symptoms of dystonia, mainly these twisting and repetitive movements or abnormal postures are currently available in the recently published scientific literature. A July 2002 issue of the Journal of Pain and Symptom Management reported a case study improved after a 42-year-old patient suffering from chronic pain. Investigators and medical researchers reported that the patient’s pain score (subjective) went below 9 to 9 (considering the 0-10 analog visual scale) after the patient breathed MMJ. In addition, the subject did not require additional analgesic medications for the next forty-eight hours.
Investigators concluded that to date there is no existing treatment plan or intervention that could lead to such an overall dramatic improvement in patients’ condition. A similar case study was conducted on another 25-year-old patient suffering from Wilson’s disease that provoked general dystonia. In the 2004 issue of the journal Movement Disorders, the Argentine research team documented their findings showing significant clinical improvement in the patient following inhalation of medical cannabis. That same year, a team of German researchers at Hanover Medical School administered 5 milligrams of active cannabinoid in medical marijuana to a 38-year-old professional pianist.
Musician dystonia was successfully treated following a single dose of THC in this placebo-controlled trial. Researchers have reported that before cannabinoid treatment; The patient did not respond to standard medications and was therefore not performing in public. However, there was a marked improvement in motor control in the affected hand of the subject and the patient was able to play technically demanding and complex literature just two hours after THC intake. The subject could not play similar pieces of music before the treatment procedure. These results clearly show that medical cannabis significantly alleviates the symptoms of this type of dystonia called focal dystonia.
In 2002, a placebo-controlled randomized study examining the use of sesame (synthetic oral cannabinoid nabolin) in 15 patients with segmental primary and generalized dystonia showed no significant improvement in their condition. Investigators have concluded that the results may be dose-related and have nothing to do with the effectiveness of medical cannabis in helping patients cope with dystonia symptoms. High doses of natural non-psychoactive CBD (cannabinoid cannabidiol) and synthetic cannabinoids in nature have been suggested by at least one recent obscure test and further investigation into the use of cannabis and cannabinoids in humans is ongoing. .